2seventy bio | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

---

2seventy bio is an immuno-oncology cell therapy company based in Cambridge, Massachusetts, focused on discovering and developing innovative therapies to disrupt the cancer treatment landscape. The company emphasizes the importance of time in the fight against cancer, aiming to provide patients with more time to enjoy life. Their expertise lies in cell therapy, oncology, gene therapy, and cancer cell biology.

🛍️ 2seventy bio Product and Pricing News →

👔 2seventy bio CEO, Management and Leadership Team →

⚔️ 2seventy bio Alternatives and Competitors →

💼 2seventy bio Hiring and Layoffs →

🤖 2seventy bio Developer, Integration and Automation News →

📈 2seventy bio Financials, Fundraising and Valuation News →

---

🛍️ 2seventy bio Product and Pricing News

---

👔 2seventy bio CEO, Management and Leadership Team

• Nick Leschly

  
  Chief Executive Officer
  undefined

• Chip Baird

  
  Chief Executive Officer
  undefined

• Vicki Eatwell

  
  Chief Financial Officer
  undefined

---

⚔️ 2seventy bio Alternatives and Competitors

• Acrivon Therapeutics
|
• Odyssey Therapeutics
|
• Vigil Neuroscience
|
• Moderna
|
• Jazz Pharmaceuticals
|
• BeiGene
|
• Syndax Pharmaceuticals
|
• Tscan Therapeutics
|
• Nkarta
|
• Dragonfly Therapeutics
|
• Oncorus
|
• Ultivue
|
• Ohana Biosciences
|
• Matterworks
|
• Roche
|
• Sanofi

---

💼 2seventy bio Hiring and Layoffs

• Charles Newton, a board member of 2seventy bio, has been appointed as an independent director at Novavax.

---

🤖 2seventy bio Developer, Integration and Automation News

---

📈 2seventy bio Financials, Fundraising and Valuation News

---

People also viewed

• Ridecell
|
• MOQO
|
• Joyride
|
• Urban Sharing
|
• Eccocar
|
• Onde
|
• Vulog